In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senju Pharmaceutical Co., Ltd.

http://www.senju.co.jp

Latest From Senju Pharmaceutical Co., Ltd.

Keeping Track: AZ’s Busy Oncology Biz, Phathom’s Voquezna Approval, And A Trio Of Complete Response Letters

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

US FDA Performance Tracker Approvals

Could The US FDA Set Clinical Trial Diversity Minimums?

Oncology Center of Excellence Director Richard Pazdur asked whether the FDA should have more conversations with sponsors about site selection and percentages of US participants.

Clinical Trials Diversity & Inclusion

Gelesis Presents Data Showing GS200, The Device That Looks Like A Drug, Treats Obesity

Results of the LIGHT UP study, which included prediabetic and diabetic subjects, could support FDA approval of GS200.

Clinical Trials Gastroenterology

PureTech Turns To Its Wholly Owned Pipeline Amid 2021 Loss

The US biotech saw a net loss last year despite increased sales and has decided to focus more on its wholly owned pipeline, which includes a safer formulation of a Roche pulmonary fibrosis product.

Companies Sales & Earnings
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Senju USA Inc
UsernamePublicRestriction

Register